Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor

Kidney International

Volumn 41, Issue 5, 1992, Pages 1297-1303

  Erley, Christiane M ^a   Harrer, Ulrike ^a   Krämer, Bernhard K ^a   Risler, Teut ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DILEVALOL; ENALAPRIL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA;

ADULT; BLOOD PRESSURE; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; GLOMERULAR FILTRATION RATE; HUMAN; LABETALOL; MALE; PROTEINURIA; RENAL CIRCULATION;

EID: 0026561486     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1992.193     Document Type: Article

References (26)

1. GLASSOCK RJ: Focus on proteinuria. Am J Nephrol 10(Suppl 11:88-93, 1990
2. HOSTETTER TH, RENNKE HG, BRENNER BM: The case for intrarenal hypertension in the initation and progression of diabetic and other glomerulopathies. Am J Med 72:375-380, 1982
3. ANDERSON S: Antihypertensive therapy and the progression of renal disease. J Hypertens 7(Suppl 7):S39-S42, 1989
4. ANDERSON S, RENNKE HG, BRENNER BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
5. BJÖRCK S, NYBERG G, MULEC H, GRANERUS G, HERLITZ H, AURELL M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293:474-474, 1986
6. HEEG JE, DE JONG PE, VAN DER HEM GK, DE ZEEUW D: Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 32:78-83, 1987
7. BEDOGNA V, VALVO E, CASAGRANDE P, BRAGGIO P, FONTANAROSA C, DAL SANTO F, ALBERTI D, MASCHIO G: Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney Int 38:101-107, 1990
8. BAUER J, REAMS G, LAL S: Renal protective effect of strict blood pressure control with enalapril therapy. Arch Int Med 147:1397-1400, 1987
9. DE VENUTO G, ANDREOTTI C, MATTAREI M, PRGORETTI G: Long-term captopril therapy at low doses reduces albumin excretion in patients with essential hypertension and no sign of renal impairment. J Hypertens 3(Suppl 2): 143-146, 1985
10. BOCHICCHIO T, SANDOVAL G, RON O, PEREZ-GROVAS H, BORDES J. HERRERA-ACOSTA J: Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensives. Kidney Int 38:873-879, 1990
11. MANN J, RITZ E: Preservation of kidney function by use of converting-enzyme inhibition for control of hypertension. Lancet i:622, 1987
12. RUILOPE LM, MIRANDA B, MORALES JM, RODICIO JL, ROMERO JC, RAIJ L: Converting enzyme inhibition in chronic renal failure. Am J Kidney Dis 13:120-126, 1989
13. RAIJ L, SHULTZ PJ, TOLINS JP: Possible mechanism for the renoprotective effect of angiotensin converting enzyme inhibitors. J Hypertens 7(Suppl 17):S53-S37, 1989
14. MYERS BR, OKARMA TB, FRIEDMAN S, BRIDGES C, ROSS J, ASSEFF S, DEEN WM: Mechanisms of proteinuria in human glomerulonephritis. J Clin Invest 70:732-746, 1982
15. DEEN WM, BRIDGES CR, BRENNER BM, MYERS BD: Heteroporous model of glomerular size-selectivity: Application to normal and nephrotic humans. Am J Physiol (Renal Fluid Electrol Physiol) 249-F374-F389, 1985
16. CLIFTON GG, POLAND M, COOK ME, WALLIN JD: The effect of single-dose dilevalol treatment on blood pressure and renal function of normotensive male volunteers. Cur Ther Res 44:86-93, 1988
17. BABA T, MURABAYASHI S, AOYAGI K, ISHIZAKI T: Effects of ' dilevalol, an R,R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension. Eur J Clin Pharm 35:9-15, 1988
18. COOK ME, CLIFTON GG, POLAND MP, FLAMENBAUM W, WALLIN JD: Effects of dilevalol and atenolol on renal function and haemodynamics of patients with mild to moderate hypertension. J Hypertens 4(Suppl 5):S504-S506, 1986
19. KRÄMER BK, JESSE U, RESS KM, SCHMÜLLING R-M, RISLER T: Enzyme-linked immunosorbent assay for urinary albumin at low concentrations. Clin Chem 33:609-611, 1987
20. MYERS BD: Pathophysiology of proteinuria in immune glomerular injury. Am J Nephrol 10(Suppl 1):19-23, 1990
21. DE ZEEUW D, HEEG JE, DE JONG PE: ACE inhibition improves glomerular permselectivity to proteins. (abstract) J Am Soc Nephrol 1:626, 1990
22. RODICIO JL, ALCAZAR JM, RUILOPE LM: Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria. Kidney Int 38:590-594, 1990
23. PARTHASARATHY N, SPIRO RG: Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 31:738-741, 1982
24. REMUZZI A, PERTICUCCI E, RUGGENENTI P, MOSCONI L, LIMONTA M, REMUZZI G: Angiotensin converting enzyme inhibition improves glomerular size-sensitivity in IgA nephropathy. Kidney Int 39:1267-1273, 1991
25. YOSHIOKA T, MITARAI T, KON V, DENN WM, RENNKE HG, ICHIKAWA I: Role for angiotensin II in an overt functional proteinuria. Kidney Int 30:538-545, 1986
26. YOSHIOKA T, RENNKE HG, SALANT DJ, DEEN WM, ICHIKAWA I: Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A study in early passive Heymann nephritis. Circ Res 61:531-538, 1987